Stock Scorecard
Stock Summary for Viemed Healthcare Inc (VMD) - $7.24 as of 1/12/2026 9:44:06 AM EST
Total Score
14 out of 30
Safety Score
28 out of 100
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for VMD
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for VMD
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for VMD
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for VMD
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for VMD (28 out of 100)
| Stock Price Rating (Max of 10) | 4 |
| Historical Stock Price Rating (Max of 10) | 4 |
| Stock Price Trend (Max of 10) | 0 |
| Book Value (Max of 10) | 3 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 3 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 3 |
| Trading Volume (Max of 10) | 4 |
| Price to Earnings (Max of 10) | 7 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for VMD
Financial Details for VMD
Company Overview |
|
|---|---|
| Ticker | VMD |
| Company Name | Viemed Healthcare Inc |
| Country | USA |
| Description | Viemed Healthcare Inc. (VMD) is a prominent player in the durable home medical equipment and post-acute respiratory healthcare sector in the United States, specializing in the management of chronic respiratory conditions. Based in Lafayette, Louisiana, the company employs cutting-edge technology and a patient-centric care model to optimize health outcomes and enhance the quality of life for its patients. With the healthcare industry's pivot towards at-home care solutions, Viemed is well-positioned for significant growth, underpinned by its expansive operational footprint and unwavering commitment to high-quality, individualized patient care. |
| Sector Name | HEALTHCARE |
| Industry Name | MEDICAL DEVICES |
| Most Recent Quarter | 9/30/2025 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 7.24 |
| Price 4 Years Ago | 7.56 |
| Last Day Price Updated | 1/12/2026 9:44:06 AM EST |
| Last Day Volume | 102,714 |
| Average Daily Volume | 144,702 |
| 52-Week High | 8.62 |
| 52-Week Low | 5.93 |
| Last Price to 52 Week Low | 22.09% |
Valuation Measures |
|
| Trailing PE | 21.29 |
| Industry PE | 56.69 |
| Sector PE | 123.98 |
| 5-Year Average PE | 32.97 |
| Free Cash Flow Ratio | 24.97 |
| Industry Free Cash Flow Ratio | 27.72 |
| Sector Free Cash Flow Ratio | 29.04 |
| Current Ratio Most Recent Quarter | 1.13 |
| Total Cash Per Share | 0.29 |
| Book Value Per Share Most Recent Quarter | 3.51 |
| Price to Book Ratio | 2.06 |
| Industry Price to Book Ratio | 4.82 |
| Sector Price to Book Ratio | 24.69 |
| Price to Sales Ratio Twelve Trailing Months | 1.10 |
| Industry Price to Sales Ratio Twelve Trailing Months | 4.22 |
| Sector Price to Sales Ratio Twelve Trailing Months | 19.33 |
| Analyst Buy Ratings | 2 |
| Analyst Strong Buy Ratings | 0 |
Share Statistics |
|
| Total Shares Outstanding | 38,017,900 |
| Market Capitalization | 275,249,596 |
| Institutional Ownership | 66.91% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | -9.80% |
| Annual Earnings Growth | 9.98% |
| Reported EPS 12 Trailing Months | 0.34 |
| Reported EPS Past Year | 0.23 |
| Reported EPS Prior Year | 0.28 |
| Net Income Twelve Trailing Months | 13,611,000 |
| Net Income Past Year | 11,265,000 |
| Net Income Prior Year | 10,243,000 |
| Quarterly Revenue Growth YOY | 24.00% |
| 5-Year Revenue Growth | 22.82% |
| Operating Margin Twelve Trailing Months | 9.69% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 11,123,000 |
| Total Cash Past Year | 17,540,000 |
| Total Cash Prior Year | 12,839,000 |
| Net Cash Position Most Recent Quarter | -8,462,000 |
| Net Cash Position Past Year | 13,951,000 |
| Long Term Debt Past Year | 3,589,000 |
| Long Term Debt Prior Year | 6,002,000 |
| Total Debt Most Recent Quarter | 19,585,000 |
| Equity to Debt Ratio Past Year | 0.97 |
| Equity to Debt Ratio Most Recent Quarter | 0.87 |
| Total Stockholder Equity Past Year | 131,393,000 |
| Total Stockholder Equity Prior Year | 113,895,000 |
| Total Stockholder Equity Most Recent Quarter | 133,608,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 5,385,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 0.14 |
| Free Cash Flow Past Year | 1,318,000 |
| Free Cash Flow Prior Year | 19,119,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | None |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.11 |
| MACD Signal | 0.15 |
| 20-Day Bollinger Lower Band | 6.27 |
| 20-Day Bollinger Middle Band | 6.89 |
| 20-Day Bollinger Upper Band | 7.51 |
| Beta | 1.25 |
| RSI | 52.14 |
| 50-Day SMA | 6.99 |
| 150-Day SMA | 7.85 |
| 200-Day SMA | 7.49 |
System |
|
| Modified | 1/10/2026 10:25:00 AM EST |